Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 53

Sort by

Sort Order Select

Journal Articles

MMF Is Associated with Worse OS in CMV Seropositive AML Patients Undergoing MUD HCT with Calcineurin-Inhibitor-Based Gvhd Prophylaxis

Rima M. Saliba, Stephanie J. Lee, Paul A Carpenter, Catherine J. Lee, Geoffrey R Hill, Richard E. Champlin, Katayoun Rezvani, Elizabeth J. Shpall, Rohtesh S. Mehta

Blood (2023) 142 (Supplement 1): 236.

https://doi.org/10.1182/blood-2023-186402

Published: 2023

Journal Articles

Post Hematopoietic Cell Transplantation Maintenance Therapy with Low-Dose Azacitidine in a Pediatric Population with High-Risk Myeloid Neoplasms

Katherine Tarlock, Emily C Merkel, Todd Cooper, Corinne Summers, Monica Thakar, Paul A Carpenter, Aleksandra Petrovic, Ross Goshorn, Robert Irwin, Ted Gooley, Marie Bleakley, Ann Dahlberg

Blood (2023) 142 (Supplement 1): 4956.

https://doi.org/10.1182/blood-2023-181256

Published: 2023

Journal Articles

Financial Toxicity and Time Toxicity in Multiple Myeloma: Prevalence, Predictors, and Impact on QOL

Rahul Banerjee, Andrew J. Cowan, Marivel Chavez-Ortega, Paul A Carpenter, Masumi Ueda Oshima, Rachel B. Salit, Phuong T Vo, Catherine J. Lee, Rohtesh S. Mehta, Nicole M. Kuderer, Veena Shankaran, Stephanie J. Lee, Christopher T. Su

Blood (2023) 142 (Supplement 1): 2386.

https://doi.org/10.1182/blood-2023-174554

Published: 2023

Journal Articles

Self-Reported Experiences of Adult Hematopoietic Cell Transplantation Survivors with COVID-19 Vaccination and Infection

Emily C. Liang, Lynn E. Onstad, Paul A. Carpenter, Steven A. Pergam, Stephanie J. Lee, Catherine Liu

Blood (2022) 140 (Supplement 1): 920–921.

https://doi.org/10.1182/blood-2022-157440

Published: 2022

Journal Articles

The Prevalence and Effects of Frailty in Chronic Graft-Versus-Host Disease

Nahid Rashid, Mukta Arora, Paul A. Carpenter, Amin M Alousi, Betty K. Hamilton, Joseph Pidala, Lynn E. Onstad, Corey Cutler, Mary E.D. Flowers, Sally Arai, Smita Bhatia, Stephanie J. Lee

Blood (2022) 140 (Supplement 1): 10519–10520.

https://doi.org/10.1182/blood-2022-167901

Published: 2022

Journal Articles

Assessment of ST2 for risk of death following graft-versus-host disease in pediatric and adult age groups

Courtney M. Rowan, Francis Pike, Kenneth R. Cooke, Robert Krance, Paul A. Carpenter, Christine Duncan, David A. Jacobsohn, Catherine M. Bollard, Conrad Russell Y. Cruz, Abhijeet Malatpure, Sherif S. Farag, Jamie Renbarger, Hao Liu, Giorgos Bakoyannis, Samir Hanash, Sophie Paczesny

Blood (2020) 135 (17): 1428–1437.

https://doi.org/10.1182/blood.2019002334

Published: 2020

Includes: Supplemental data

Journal Articles

Quality of Life of Informal Caregivers of Hematopoietic Cell Transplant Recipients

Kareem Jamani, MD, Lynn E. Onstad, ScM, Rachel B. Salit, MD, Mary E. Flowers, MD, Paul A. Carpenter, MD, Stephanie J. Lee, MD PhD

Blood (2017) 130 (Supplement 1): 280.

https://doi.org/10.1182/blood.V130.Suppl_1.280.280

Published: 2017

Journal Articles

Posttransplant feasibility study of nilotinib prophylaxis for high-risk Philadelphia chromosome positive leukemia

Paul A. Carpenter, Laura Johnston, Hugo F. Fernandez, Jerald P. Radich, Michael J. Mauro, Mary E. D. Flowers, Paul J. Martin, Theodore A. Gooley

Blood (2017) 130 (9): 1170–1172.

https://doi.org/10.1182/blood-2017-03-771121

Published: 2017

Includes: Supplemental data

Journal Articles

An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease

Paul J. Martin, Barry E. Storer, Yoshihiro Inamoto, Mary E. D. Flowers, Paul A. Carpenter, Joseph Pidala, Jeanne Palmer, Mukta Arora, Madan Jagasia, Sally Arai, Corey S. Cutler, Stephanie J. Lee

Blood (2017) 130 (3): 360–367.

https://doi.org/10.1182/blood-2017-03-775767

Published: 2017

Includes: Supplemental data

Journal Articles

Vitamin A to reduce gut leak and GVHD?

Paul A. Carpenter

Blood (2017) 129 (20): 2715–2717.

https://doi.org/10.1182/blood-2017-03-773226

Published: 2017

Journal Articles

Replication of associations between genetic polymorphisms and chronic graft-versus-host disease

Blood (2016) 128 (20): 2450–2456.

https://doi.org/10.1182/blood-2016-07-728063

Published: 2016

Includes: Supplemental data

Journal Articles

Genetic risk factors for sclerotic graft-versus-host disease

Yoshihiro Inamoto, Paul J. Martin, Mary E. D. Flowers, Stephanie J. Lee, Paul A. Carpenter, Edus H. Warren, Daniel E. Geraghty, Ni Lee, Michael J. Boeckh, Barry E. Storer, David M. Levine, Wenhong Fan, Lue-Ping Zhao, John A. Hansen

Blood (2016) 128 (11): 1516–1524.

https://doi.org/10.1182/blood-2016-05-715342

Published: 2016

Includes: Supplemental data

Journal Articles

How I vaccinate blood and marrow transplant recipients

Paul A. Carpenter, Janet A. Englund

Blood (2016) 127 (23): 2824–2832.

https://doi.org/10.1182/blood-2015-12-550475

Published: 2016

Includes: Supplemental data

Journal Articles

Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation

Marco Mielcarek, Terry Furlong, Paul V. O’Donnell, Barry E. Storer, Jeannine S. McCune, Rainer Storb, Paul A. Carpenter, Mary E. D. Flowers, Frederick R. Appelbaum, Paul J. Martin

Blood (2016) 127 (11): 1502–1508.

https://doi.org/10.1182/blood-2015-10-672071

Published: 2016

Includes: Supplemental data

Journal Articles

Genetic Risk Factors for Sclerotic Graft-Versus-Host Disease

Yoshihiro Inamoto, MD PhD, Paul J. Martin, MD, Mary E. Flowers, MD, Stephanie J. Lee, MD MPH, Paul A. Carpenter, MD, Edus Houston Warren, MD PhD, Michael Boeckh, MD, Barry E. Storer, PhD, David Levine, PhD, Wenhong Fan, Lue Ping Zhao, PhD, John A. Hansen, MD

Blood (2014) 124 (21): 665.

https://doi.org/10.1182/blood.V124.21.665.665

Published: 2014

Journal Articles

Posttransplant Cyclophosphamide for Prevention of Graft-Versus-Host Disease after HLA-Matched Related and Unrelated Donor Peripheral Blood Stem Cell Transplantation

Marco Mielcarek, MD, Terrence Furlong, Paul V. O'Donnell, MD PhD, Barry E. Storer, PhD, Rainer F. Storb, MD, Paul A. Carpenter, MD, Paul J. Martin, MD

Blood (2014) 124 (21): 1161.

https://doi.org/10.1182/blood.V124.21.1161.1161

Published: 2014

Journal Articles

Failure-free survival after initial systemic treatment of chronic graft-versus-host disease

Yoshihiro Inamoto, Mary E. D. Flowers, Brenda M. Sandmaier, Sahika Z. Aki, Paul A. Carpenter, Stephanie J. Lee, Barry E. Storer, Paul J. Martin

Blood (2014) 124 (8): 1363–1371.

https://doi.org/10.1182/blood-2014-03-563544

Published: 2014

Includes: Supplemental data

Journal Articles

Transplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimens

Blood (2014) 123 (10): 1615–1620.

https://doi.org/10.1182/blood-2013-10-535716

Published: 2014

Journal Articles

Failure-Free Survival After Initial Systemic Treatment Of Chronic GVHD

Yoshihiro Inamoto, MD, PhD, Paul J. Martin, MD, Brenda M. Sandmaier, MD, Sahika Aki, MD, Paul A. Carpenter, MD, Stephanie J. Lee, MD, MPH, Barry E. Storer, PhD, Mary E. D. Flowers, MD

Blood (2013) 122 (21): 2053.

https://doi.org/10.1182/blood.V122.21.2053.2053

Published: 2013

Journal Articles

Efficacy and Safety Of Lower-Dose Glucocorticoids For Initial Treatment Of Acute Graft-Versus-Host Disease: A Randomized Controlled Trial

Marco Mielcarek, MD, Terrence Furlong, Barry E. Storer, PhD, Margaret L. Green, MD, Paul A. Carpenter, MD, George B McDonald, MD, Mary E. D. Flowers, MD, Rainer Storb, MD, Frederick R. Appelbaum, MD, Michael Boeckh, MD, Paul J. Martin, MD

Blood (2013) 122 (21): 703.

https://doi.org/10.1182/blood.V122.21.703.703

Published: 2013

NARROW

MMF Is Associated with Worse OS in CMV Seropositive AML Patients Undergoing MUD HCT with Calcineurin-Inhibitor-Based Gvhd Prophylaxis

Post Hematopoietic Cell Transplantation Maintenance Therapy with Low-Dose Azacitidine in a Pediatric Population with High-Risk Myeloid Neoplasms

Financial Toxicity and Time Toxicity in Multiple Myeloma: Prevalence, Predictors, and Impact on QOL

Self-Reported Experiences of Adult Hematopoietic Cell Transplantation Survivors with COVID-19 Vaccination and Infection

The Prevalence and Effects of Frailty in Chronic Graft-Versus-Host Disease

Assessment of ST2 for risk of death following graft-versus-host disease in pediatric and adult age groups

Quality of Life of Informal Caregivers of Hematopoietic Cell Transplant Recipients

Posttransplant feasibility study of nilotinib prophylaxis for high-risk Philadelphia chromosome positive leukemia

An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease

Vitamin A to reduce gut leak and GVHD?

Replication of associations between genetic polymorphisms and chronic graft-versus-host disease

Genetic risk factors for sclerotic graft-versus-host disease

How I vaccinate blood and marrow transplant recipients

Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation

Genetic Risk Factors for Sclerotic Graft-Versus-Host Disease

Posttransplant Cyclophosphamide for Prevention of Graft-Versus-Host Disease after HLA-Matched Related and Unrelated Donor Peripheral Blood Stem Cell Transplantation

Failure-free survival after initial systemic treatment of chronic graft-versus-host disease

Transplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimens

Failure-Free Survival After Initial Systemic Treatment Of Chronic GVHD

Efficacy and Safety Of Lower-Dose Glucocorticoids For Initial Treatment Of Acute Graft-Versus-Host Disease: A Randomized Controlled Trial

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only